BIOMAT Database Logo BIOMAT Database Logo

Phenytoin hypersensitivity syndrome with fatal evolution. 1999

M D Quiñones, and C Valero, and M Salcedo, and I Sánchez, and J Jerez, and P Matorras
Section of Allergy, Service of Internal Medicine, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes
D017093 Liver Failure Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed) Hepatic Failure
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

M D Quiñones, and C Valero, and M Salcedo, and I Sánchez, and J Jerez, and P Matorras
Fatal phenytoin hypersensitivity syndrome.
December 1999, Postgraduate medical journal,
M D Quiñones, and C Valero, and M Salcedo, and I Sánchez, and J Jerez, and P Matorras
Fatal benign phenytoin hypersensitivity.
October 1977, Lancet (London, England),
M D Quiñones, and C Valero, and M Salcedo, and I Sánchez, and J Jerez, and P Matorras
Phenytoin hypersensitivity syndrome.
January 1997, Indian journal of dermatology, venereology and leprology,
M D Quiñones, and C Valero, and M Salcedo, and I Sánchez, and J Jerez, and P Matorras
Phenytoin hypersensitivity syndrome.
January 1987, The Journal of emergency medicine,
M D Quiñones, and C Valero, and M Salcedo, and I Sánchez, and J Jerez, and P Matorras
[Phenytoin hypersensitivity syndrome].
November 1994, Anales de medicina interna (Madrid, Spain : 1984),
M D Quiñones, and C Valero, and M Salcedo, and I Sánchez, and J Jerez, and P Matorras
Phenytoin hypersensitivity syndrome.
June 2001, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,
M D Quiñones, and C Valero, and M Salcedo, and I Sánchez, and J Jerez, and P Matorras
Phenytoin hypersensitivity syndrome.
February 1996, Journal of the Mississippi State Medical Association,
M D Quiñones, and C Valero, and M Salcedo, and I Sánchez, and J Jerez, and P Matorras
Anticonvulsant hypersensitivity syndrome with fatal outcome.
January 2002, European journal of dermatology : EJD,
M D Quiñones, and C Valero, and M Salcedo, and I Sánchez, and J Jerez, and P Matorras
Agranulocytosis following phenytoin-induced hypersensitivity syndrome.
June 2009, Brain & development,
M D Quiñones, and C Valero, and M Salcedo, and I Sánchez, and J Jerez, and P Matorras
A case of phenytoin hypersensitivity syndrome.
September 2002, Journal of drugs in dermatology : JDD,
Copied contents to your clipboard!